002864 盘龙药业
已收盘 10-31 15:00:00
资讯
新帖
简况
盘龙药业(002864)9月30日股东户数2.09万户,较上期减少10.84%
证券之星 · 10-28
盘龙药业(002864)9月30日股东户数2.09万户,较上期减少10.84%
图解盘龙药业三季报:第三季度单季净利润同比下降0.83%
证券之星 · 10-27
图解盘龙药业三季报:第三季度单季净利润同比下降0.83%
股市必读:盘龙药业(002864)10月24日董秘有最新回复
证券之星 · 10-26
股市必读:盘龙药业(002864)10月24日董秘有最新回复
盘龙药业:生产销售抗流感药品
证券之星 · 10-24
盘龙药业:生产销售抗流感药品
盘龙药业(002864)披露变更持续督导保荐代表人公告,10月9日股价下跌0.47%
证券之星 · 10-09
盘龙药业(002864)披露变更持续督导保荐代表人公告,10月9日股价下跌0.47%
盘龙药业:高端仿制药领域实现零的突破,强势叩开化药市场大门
中金财经 · 09-29
盘龙药业:高端仿制药领域实现零的突破,强势叩开化药市场大门
股市必读:盘龙药业(002864)9月26日董秘有最新回复
证券之星 · 09-28
股市必读:盘龙药业(002864)9月26日董秘有最新回复
盘龙药业(002864.SZ):PLJT-001洛索洛芬钠凝胶贴膏获境内生产药品注册上市许可受理通知书
智通财经 · 09-26
盘龙药业(002864.SZ):PLJT-001洛索洛芬钠凝胶贴膏获境内生产药品注册上市许可受理通知书
股市必读:盘龙药业(002864)9月24日董秘有最新回复
证券之星 · 09-24
股市必读:盘龙药业(002864)9月24日董秘有最新回复
盘龙药业:拟购置新楼作为生产基地员工公寓
证券之星 · 09-24
盘龙药业:拟购置新楼作为生产基地员工公寓
盘龙药业:选举朱文锋为第五届董事会职工代表董事
证券日报网 · 09-15
盘龙药业:选举朱文锋为第五届董事会职工代表董事
盘龙药业:9月10日将举行2025年半年度网上业绩说明会
证券日报网 · 09-05
盘龙药业:9月10日将举行2025年半年度网上业绩说明会
股市必读:盘龙药业(002864)9月4日董秘有最新回复
证券之星 · 09-04
股市必读:盘龙药业(002864)9月4日董秘有最新回复
盘龙药业董秘吴杰荣获第十一届金麒麟·金牌董秘五年功勋奖
新浪财经 · 09-01
盘龙药业董秘吴杰荣获第十一届金麒麟·金牌董秘五年功勋奖
图解盘龙药业中报:第二季度单季净利润同比增长1.33%
证券之星 · 08-27
图解盘龙药业中报:第二季度单季净利润同比增长1.33%
盘龙药业最新公告:收到盘龙七凝胶贴膏申请受理通知书
证券之星 · 08-20
盘龙药业最新公告:收到盘龙七凝胶贴膏申请受理通知书
盘龙药业:公司不存在应披露而未披露的重大风险信息
证券之星 · 08-19
盘龙药业:公司不存在应披露而未披露的重大风险信息
盘龙药业深耕秦药 推动中医药高质量发展
华商网 · 07-13
盘龙药业深耕秦药 推动中医药高质量发展
盘龙药业:6月23日进行路演,万家基金、深圳市同城投资管理有限公司等多家机构参与
证券之星 · 07-01
盘龙药业:6月23日进行路演,万家基金、深圳市同城投资管理有限公司等多家机构参与
盘龙药业:详解研发战略与成本优势
财中社 · 06-20
盘龙药业:详解研发战略与成本优势
加载更多
公司概况
公司名称:
陕西盘龙药业集团股份有限公司
所属行业:
医药制造业
上市日期:
2017-11-16
主营业务:
陕西盘龙药业集团股份有限公司的主营业务是药材规范化种植、药品生产、研发、销售和医药物流。公司的主要产品是盘龙七片、盘龙七药酒、金茵利胆胶囊和克比热提片,以及复方醋酸棉酚片、醋酸棉酚原料药。公司荣获多项荣誉,其中盘龙药业荣获“国家级绿色工厂”、第七届“全国文明单位”,盘龙生态产业园获“陕西省中医药文化宣传教育基地”,并成功取得中国合格评定国家认可委员会(CNAS)实验室认可证书。
发行价格:
10.03
{"stockData":{"symbol":"002864","market":"SZ","secType":"STK","nameCN":"盘龙药业","latestPrice":30.37,"timestamp":1761894213000,"preClose":29.82,"halted":0,"volume":2701558,"delay":0,"changeRate":0.0184,"floatShares":74190700,"shares":106000000,"eps":1.1339,"marketStatus":"已收盘","change":0.55,"latestTime":"10-31 15:00:00","open":29.87,"high":30.52,"low":29.83,"amount":81852800,"amplitude":0.0231,"askPrice":30.38,"askSize":66,"bidPrice":30.37,"bidSize":852,"shortable":0,"etf":0,"ttmEps":1.1339,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1762133400000},"marketStatusCode":5,"adr":0,"adjPreClose":29.82,"symbolType":"stock","openAndCloseTimeList":[[1761874200000,1761881400000],[1761886800000,1761894000000]],"highLimit":32.8,"lowLimit":26.84,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":106280960,"isCdr":false,"pbRate":1.88,"roa":"--","peRate":26.783667,"roe":"5.39%","epsLYR":1.15,"committee":0.636687,"marketValue":3228000000,"turnoverRate":0.0364,"status":0,"floatMarketCap":2253000000},"requestUrl":"/m/hq/s/002864","defaultTab":"news","newsList":[{"id":"2578939133","title":"盘龙药业(002864)9月30日股东户数2.09万户,较上期减少10.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578939133","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578939133?lang=zh_cn&edition=full","pubTime":"2025-10-28 17:36","pubTimestamp":1761644189,"startTime":"0","endTime":"0","summary":"证券之星消息,近日盘龙药业披露,截至2025年9月30日公司股东户数为2.09万户,较6月30日减少2538.0户,减幅为10.84%。在中药行业个股中,盘龙药业股东户数低于行业平均水平,截至9月30日,中药行业平均股东户数为5.36万户。从股价来看,2025年6月30日至2025年9月30日,盘龙药业区间涨幅为4.84%,在此期间股东户数减少2538.0户,减幅为10.84%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800031964.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"gpt_icon":0},{"id":"2578655627","title":"图解盘龙药业三季报:第三季度单季净利润同比下降0.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578655627","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578655627?lang=zh_cn&edition=full","pubTime":"2025-10-28 02:58","pubTimestamp":1761591525,"startTime":"0","endTime":"0","summary":"证券之星消息,盘龙药业2025年三季报显示,公司主营收入8.41亿元,同比上升17.37%;归母净利润8980.59万元,同比上升0.26%;扣非净利润8247.01万元,同比上升2.33%;其中2025年第三季度,公司单季度主营收入2.67亿元,同比上升2.24%;单季度归母净利润2967.07万元,同比下降0.83%;单季度扣非净利润2961.26万元,同比下降0.82%;负债率29.79%,投资收益-17.42万元,财务费用-1268.74万元,毛利率52.69%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800002332.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864"],"gpt_icon":0},{"id":"2578065008","title":"股市必读:盘龙药业(002864)10月24日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2578065008","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578065008?lang=zh_cn&edition=full","pubTime":"2025-10-27 05:58","pubTimestamp":1761515896,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘,盘龙药业报收于31.43元,上涨0.42%,换手率5.02%,成交量3.73万手,成交额1.17亿元。董秘最新回复投资者: 董秘您好,公司有生产和销售抗流感药品吗?交易信息汇总资金流向10月24日主力资金净流出139.59万元;游资资金净流出181.43万元;散户资金净流入321.02万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700001678.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"gpt_icon":0},{"id":"2577593056","title":"盘龙药业:生产销售抗流感药品","url":"https://stock-news.laohu8.com/highlight/detail?id=2577593056","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577593056?lang=zh_cn&edition=full","pubTime":"2025-10-24 16:30","pubTimestamp":1761294648,"startTime":"0","endTime":"0","summary":"证券之星消息,盘龙药业10月24日在投资者关系平台上答复投资者关心的问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400028524.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"gpt_icon":0},{"id":"2574169046","title":"盘龙药业(002864)披露变更持续督导保荐代表人公告,10月9日股价下跌0.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574169046","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574169046?lang=zh_cn&edition=full","pubTime":"2025-10-09 23:04","pubTimestamp":1760022257,"startTime":"0","endTime":"0","summary":"截至2025年10月9日收盘,盘龙药业报收于29.4元,较前一交易日下跌0.47%,最新总市值为31.25亿元。该股当日开盘29.64元,最高29.65元,最低29.1元,成交额达5329.22万元,换手率为2.45%。公司近日发布公告称,陕西盘龙药业集团股份有限公司于近日收到中泰证券出具的关于变更持续督导保荐代表人的报告。公司董事会对王彦忠在持续督导期间所做工作表示感谢。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025100900034984.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"gpt_icon":0},{"id":"2571772608","title":"盘龙药业:高端仿制药领域实现零的突破,强势叩开化药市场大门","url":"https://stock-news.laohu8.com/highlight/detail?id=2571772608","media":"中金财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571772608?lang=zh_cn&edition=full","pubTime":"2025-09-29 11:20","pubTimestamp":1759116001,"startTime":"0","endTime":"0","summary":"近日,盘龙药业传来重磅消息——其在研产品洛索洛芬钠凝胶贴膏收到国家药监局下发的仿制药上市许可申请《受理通知书》。这不仅标志着盘龙药业在化药高端仿制药领域实现零的突破,更成为企业发展过程中具有划时代意义的关键节点。齐华锋同时透露,后续盘龙药业将围绕风湿骨病领域,陆续推出多款凝胶贴膏产品。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202509/29/20250929314401.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202509/29/20250929314401.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20250929/31680368.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","002864"],"gpt_icon":0},{"id":"2571824886","title":"股市必读:盘龙药业(002864)9月26日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2571824886","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571824886?lang=zh_cn&edition=full","pubTime":"2025-09-29 03:57","pubTimestamp":1759089430,"startTime":"0","endTime":"0","summary":"截至2025年9月26日收盘,盘龙药业报收于29.3元,下跌0.41%,换手率2.48%,成交量1.84万手,成交额5381.44万元。董秘最新回复投资者: 董秘,你好,为何不正面回答之前在互动易投资者询问的:为支持西渝高铁建设,公司拆除了原职工宿舍,是否有货币补偿这个问题?如果有货币补偿会不会在第三季度报告里有所体现董秘: 尊敬的投资者您好!当日关注点来自交易信息汇总:9月26日主力资金净流出6.6万元,散户资金净流入422.95万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092900001438.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"gpt_icon":0},{"id":"2570008643","title":"盘龙药业(002864.SZ):PLJT-001洛索洛芬钠凝胶贴膏获境内生产药品注册上市许可受理通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2570008643","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570008643?lang=zh_cn&edition=full","pubTime":"2025-09-26 16:19","pubTimestamp":1758874779,"startTime":"0","endTime":"0","summary":"智通财经APP讯,盘龙药业 发布公告,近日,公司在研产品洛索洛芬钠凝胶贴膏收到国家药品监督管理局下发的仿制药上市许可申请《受理通知书》。洛索洛芬钠凝胶贴膏,为治疗骨关节炎、肌肉痛、外伤后的肿胀或疼痛的凝胶贴膏。PLJT-001中有效成分为洛索洛芬钠,苯丙酸类非甾体抗炎药,具有显著的抗炎镇痛作用,尤其是镇痛作用较强。洛索洛芬钠为前体药物,经皮肤吸收后,转变为活性代谢物反式-OH体发挥作用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1349848.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"盘龙药业(002864.SZ):PLJT-001洛索洛芬钠凝胶贴膏获境内生产药品注册上市许可受理通知书","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002864"],"gpt_icon":0},{"id":"2570081401","title":"股市必读:盘龙药业(002864)9月24日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2570081401","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570081401?lang=zh_cn&edition=full","pubTime":"2025-09-25 01:34","pubTimestamp":1758735254,"startTime":"0","endTime":"0","summary":"截至2025年9月24日收盘,盘龙药业报收于29.83元,上涨0.81%,换手率2.96%,成交量2.19万手,成交额6519.0万元。董秘最新回复投资者: 董秘你好,公司有意愿溢价收购实控人名下的房地产企业吗?公司所有的投资与收购行为均严格遵循法律法规及公司章程的规定,以公平、公正的市场原则为基础进行审慎决策。如有相关进展,公司将严格按照监管要求及时履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092500000701.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"gpt_icon":0},{"id":"2569281727","title":"盘龙药业:拟购置新楼作为生产基地员工公寓","url":"https://stock-news.laohu8.com/highlight/detail?id=2569281727","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569281727?lang=zh_cn&edition=full","pubTime":"2025-09-24 09:12","pubTimestamp":1758676344,"startTime":"0","endTime":"0","summary":"证券之星消息,盘龙药业09月23日在投资者关系平台上答复投资者关心的问题。公司的愿景是“让百姓吃上放心药,让员工过上好日子”,公司为妥善解决生产基地员工的住宿需求,拟购置新楼作为公司专门的生产基地员工公寓。具体情况可详见公司于2025年9月20日在巨潮资讯网披露的《关于购买资产暨关联交易的公告》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092400009298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"gpt_icon":0},{"id":"2567414827","title":"盘龙药业:选举朱文锋为第五届董事会职工代表董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2567414827","media":"证券日报网","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567414827?lang=zh_cn&edition=full","pubTime":"2025-09-15 22:10","pubTimestamp":1757945400,"startTime":"0","endTime":"0","summary":"证券日报网讯9月15日晚间,盘龙药业发布公告称,公司于2025年9月12日在公司会议室召开职工代表大会,经与会职工代表民主选举,同意朱文锋先生为公司第五届董事会职工代表董事。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-15/doc-infqqytz4310090.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-15/doc-infqqytz4310090.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","002864"],"gpt_icon":0},{"id":"2565456827","title":"盘龙药业:9月10日将举行2025年半年度网上业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2565456827","media":"证券日报网","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565456827?lang=zh_cn&edition=full","pubTime":"2025-09-05 19:39","pubTimestamp":1757072340,"startTime":"0","endTime":"0","summary":"证券日报网讯9月5日晚间,盘龙药业发布公告称,公司将于2025年9月10日(星期三)15:00-17:00举行2025年半年度网上业绩说明会。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-05/doc-infpmzef7593151.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-05/doc-infpmzef7593151.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["002864","BK0239"],"gpt_icon":0},{"id":"2565585423","title":"股市必读:盘龙药业(002864)9月4日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2565585423","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565585423?lang=zh_cn&edition=full","pubTime":"2025-09-05 05:53","pubTimestamp":1757022797,"startTime":"0","endTime":"0","summary":"截至2025年9月4日收盘,盘龙药业报收于29.13元,上涨0.21%,换手率3.26%,成交量2.42万手,成交额7065.95万元。董秘最新回复投资者: 2025年中报中并未说明1.8亿投资建设的康养医院项目进展情况,能否告知计划何时完工?当日关注点来自交易信息汇总:9月4日主力资金净流入50.54万元,显示主力对盘龙药业短期走势持相对积极态度。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090500004645.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"gpt_icon":0},{"id":"2564897181","title":"盘龙药业董秘吴杰荣获第十一届金麒麟·金牌董秘五年功勋奖","url":"https://stock-news.laohu8.com/highlight/detail?id=2564897181","media":"新浪财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564897181?lang=zh_cn&edition=full","pubTime":"2025-09-01 16:15","pubTimestamp":1756714500,"startTime":"0","endTime":"0","summary":"登录新浪财经APP 搜索查看更多考评等级 专题:专题:第十一届金麒麟·金牌董秘荣誉榜单揭晓!在本次备受瞩目的评选中,盘龙药业董事会秘书吴杰凭借卓越的专业能力和出色的工作表现荣耀加冕,荣获第十一届金麒麟·金牌董秘五年功勋奖。 本届荣获金麒麟·金牌董秘称号的盘龙药业董秘吴杰,正是这一群体中的杰出代表。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/roll/2025-09-01/doc-infnyqec9386718.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["002864","BK0239"],"gpt_icon":0},{"id":"2562724212","title":"图解盘龙药业中报:第二季度单季净利润同比增长1.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562724212","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562724212?lang=zh_cn&edition=full","pubTime":"2025-08-28 03:03","pubTimestamp":1756321387,"startTime":"0","endTime":"0","summary":"证券之星消息,盘龙药业2025年中报显示,公司主营收入5.74亿元,同比上升26.06%;归母净利润6013.52万元,同比上升0.81%;扣非净利润5285.75万元,同比上升4.19%;其中2025年第二季度,公司单季度主营收入3.24亿元,同比上升32.04%;单季度归母净利润2888.59万元,同比上升1.33%;单季度扣非净利润2410.46万元,同比下降9.01%;负债率29.46%,投资收益-11.95万元,财务费用-1185.77万元,毛利率51.08%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082800002280.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864"],"gpt_icon":0},{"id":"2560172415","title":"盘龙药业最新公告:收到盘龙七凝胶贴膏申请受理通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2560172415","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560172415?lang=zh_cn&edition=full","pubTime":"2025-08-20 18:41","pubTimestamp":1755686489,"startTime":"0","endTime":"0","summary":"盘龙药业(002864.SZ)公告称,公司近日收到国家药品监督管理局核准下发的盘龙七凝胶贴膏注册临床试验的受理通知书。该产品是根据独家品种盘龙七药酒制成的中药改良型创新药,功能主治为活血化瘀、祛风除湿、消肿止痛,适用于膝骨关节炎(气滞血瘀证)。如临床试验进展顺利,将丰富完善公司产品线布局、提升公司产品竞争力。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082000037224.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"gpt_icon":0},{"id":"2560169984","title":"盘龙药业:公司不存在应披露而未披露的重大风险信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2560169984","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560169984?lang=zh_cn&edition=full","pubTime":"2025-08-19 16:24","pubTimestamp":1755591864,"startTime":"0","endTime":"0","summary":"证券之星消息,盘龙药业08月19日在投资者关系平台上答复投资者关心的问题。请公司管理层分析二级市场中存在的问题,维护投资者利益,谢谢!公司严格遵守相关法律法规,坚持真实、准确、完整、及时、公平的信息披露原则,不存在应披露而未披露的重大风险信息。关于二级市场股价波动,受宏观经济环境、行业政策、市场情绪等多重因素影响,股价波动属于正常市场现象。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081900027456.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"gpt_icon":0},{"id":"2551594721","title":"盘龙药业深耕秦药 推动中医药高质量发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2551594721","media":"华商网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551594721?lang=zh_cn&edition=full","pubTime":"2025-07-14 00:11","pubTimestamp":1752423067,"startTime":"0","endTime":"0","summary":"陕西的中医药资源丰富、文化厚重,秦岭、巴山更是中药宝库,太白山的七药系列等野生中药材独具特色。位于秦岭腹地柞水县的盘龙药业,正深耕秦药,推动中医药高质量发展,打造秦药头部品牌。7月12日,盘龙药业综合制剂中心的智慧工厂数据大屏实时监控生产各环节,保障药品标准化、高质量生产。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714001414a4481630&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714001414a4481630&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["561510","562390","002864","BK0239"],"gpt_icon":0},{"id":"2548006095","title":"盘龙药业:6月23日进行路演,万家基金、深圳市同城投资管理有限公司等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2548006095","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548006095?lang=zh_cn&edition=full","pubTime":"2025-07-01 20:06","pubTimestamp":1751371613,"startTime":"0","endTime":"0","summary":"证券之星消息,2025年7月1日盘龙药业发布公告称公司于2025年6月23日进行路演,万家基金杨梦朝、深圳市同城投资管理有限公司裘伯元、招商基金夏帅、鹏扬基金曹敏、长城基金龙宇飞、长城证券蔡航 刘鹏、标普全球市场财智孔冰逸、荣疆投资彭卫、银河证券宋丽莹、东方财富证券何玮参与。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070100033401.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"gpt_icon":0},{"id":"2544121077","title":"盘龙药业:详解研发战略与成本优势","url":"https://stock-news.laohu8.com/highlight/detail?id=2544121077","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544121077?lang=zh_cn&edition=full","pubTime":"2025-06-20 19:19","pubTimestamp":1750418373,"startTime":"0","endTime":"0","summary":"6月20日,盘龙药业发布公告,2025年6月18日,公司在公司举行了投资者关系活动,接待了多家投资机构的调研。活动中,公司就投资者提出的多个问题进行了详细回复,主要涉及研发战略、成本优势及未来营销计划。关于成本优势,公司表示在中药配方颗粒业务中已建立显著的产业链协同优势,依托全资子公司实现核心原料的稳定供应与成本优化。2025年一季度,盘龙药业实现收入2.50亿元,归母净利润3125万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506201920409787e4bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506201920409787e4bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["562390","BK0239","002864","561510"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1761926389928,"stockEarnings":[{"period":"1week","weight":-0.0473},{"period":"1month","weight":0.0095},{"period":"3month","weight":-0.0493},{"period":"6month","weight":0.1225},{"period":"1year","weight":0.0761},{"period":"ytd","weight":-0.0056}],"compareEarnings":[{"period":"1week","weight":0.0164},{"period":"1month","weight":0.0268},{"period":"3month","weight":0.1199},{"period":"6month","weight":0.2159},{"period":"1year","weight":0.2206},{"period":"ytd","weight":0.1895}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"陕西盘龙药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"20868人(较上一季度减少10.84%)","perCapita":"3555股","listingDate":"2017-11-16","address":"陕西省商洛市柞水县盘龙生态产业园","registeredCapital":"10628万元","survey":" 陕西盘龙药业集团股份有限公司的主营业务是药材规范化种植、药品生产、研发、销售和医药物流。公司的主要产品是盘龙七片、盘龙七药酒、金茵利胆胶囊和克比热提片,以及复方醋酸棉酚片、醋酸棉酚原料药。公司荣获多项荣誉,其中盘龙药业荣获“国家级绿色工厂”、第七届“全国文明单位”,盘龙生态产业园获“陕西省中医药文化宣传教育基地”,并成功取得中国合格评定国家认可委员会(CNAS)实验室认可证书。","listedPrice":10.03},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.5","shortVersion":"4.35.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"盘龙药业(002864)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供盘龙药业(002864)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"盘龙药业,002864,盘龙药业股票,盘龙药业股票老虎,盘龙药业股票老虎国际,盘龙药业行情,盘龙药业股票行情,盘龙药业股价,盘龙药业股市,盘龙药业股票价格,盘龙药业股票交易,盘龙药业股票购买,盘龙药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"盘龙药业(002864)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供盘龙药业(002864)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}